Find the lab setup that fits your research, from shared and pre-equipped private labs to adaptable spaces and custom build-outs. All within a hand-picked community at Switzerland’s flagship life sciences campus.
Lab space rentals for every stage of growth. Find your fit.
A flexible, low-barrier option designed to help early-stage teams get up and running quickly without the cost of building out a lab from scratch.
Setting up our research operations in the shared lab was crucial because we could start working on advancing science right away, producing more data, and expanding our technology platform. We didn’t have to spend time or money on establishing our own lab infrastructure.”
Friedrich Metzger, CEO Versameb, Main Campus alumni
Your own private laboratory with essential equipment already in place. Designed for small life sciences teams that need dedicated space and the flexibility to add specialized equipment for their research. Available January 2027 at our newest building, ALL.
Move straight into fully fitted biology, chemistry and analytical labs. Choose a modern space that fits your company and configure it around your research needs.
We chose the private labs at Switzerland Innovation Park Basel Area’s Main Campus for their modern infrastructure and exceptional life science network. The purpose-built lab facilities and strong support framework have been great, enabling us to customize our operations, focus on groundbreaking research, and advance scientific discoveries."
Markus Meyer, EVP of Alentis Therapeutics
For larger teams with more complex requirements, custom build-out labs offer the flexibility to create a space around your exact needs.
Discover how Basilea uses Main Campus to support its people, science and growth while benefiting from one of Switzerland’s leading life sciences ecosystems.
What biotech founders should check before renting lab space in the Basel Area – from hidden costs and compliance to flexibility, IP and speed to first experiment.
In this interview with Dr. Simon Ittig, CEO of T3 Pharma, we explore how they moved from academia to entrepreneurship, scaled within Basel’s vibrant biotech hub, and became part of Boehringer Ingelheim’s CHF 450 million acquisition, all while shaping the next generation of cancer care.
